182 related articles for article (PubMed ID: 34761641)
1. The place of Omalizumab in the treatment of Carboplatin hypersensitivity.
Benderli Cihan Y
J BUON; 2021; 26(5):2205. PubMed ID: 34761641
[No Abstract] [Full Text] [Related]
2. Hypersensitivity reactions to carboplatin in children.
Lazzareschi I; Ruggiero A; Riccardi R; Attinà G; Colosimo C; Lasorella A
J Neurooncol; 2002 May; 58(1):33-7. PubMed ID: 12160138
[TBL] [Abstract][Full Text] [Related]
3. Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels.
Ojaimi S; Harnett PR; Fulcher DA
J Allergy Clin Immunol Pract; 2014; 2(1):105-6. PubMed ID: 24565780
[No Abstract] [Full Text] [Related]
4. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.
Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M
J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175
[No Abstract] [Full Text] [Related]
5. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.
Heffler E; Fichera S; Nicolosi G; Crimi N
J Allergy Clin Immunol Pract; 2017; 5(3):852-854. PubMed ID: 28258855
[No Abstract] [Full Text] [Related]
6. Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab.
Phillips-Angles E; Barranco P; Lluch-Bernal M; Dominguez-Ortega J; López-Carrasco V; Quirce S
J Allergy Clin Immunol Pract; 2017; 5(3):842-845. PubMed ID: 28117272
[No Abstract] [Full Text] [Related]
7. Role of omalizumab in insulin hypersensitivity: a case report and review of the literature.
Mishra S; Connors L; Tugwell B
Diabet Med; 2018 May; 35(5):663-666. PubMed ID: 29381818
[TBL] [Abstract][Full Text] [Related]
8. Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole.
Lee EY; Freedman O; Castells M; Vadas P
Ann Allergy Asthma Immunol; 2021 Sep; 127(3):378-379. PubMed ID: 34004279
[No Abstract] [Full Text] [Related]
9. Off-Label Uses of Omalizumab.
El-Qutob D
Clin Rev Allergy Immunol; 2016 Feb; 50(1):84-96. PubMed ID: 26048266
[TBL] [Abstract][Full Text] [Related]
10. Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab.
Prieto-García A; Noguerado B; Rojas P; Torrado I; Rodríguez-Fernández A; Tornero P
J Investig Allergol Clin Immunol; 2019 Feb; 29(1):53-55. PubMed ID: 30785102
[No Abstract] [Full Text] [Related]
11. Promising Use of the New Biologics in the Management of Drug-Induced Hypersensitivity Reactions: Preliminary Approaches.
Calogiuri G; Brockow K; Nettis E; Macchia L; Foti C; Vacca A
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1456-1469. PubMed ID: 32410566
[TBL] [Abstract][Full Text] [Related]
12. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.
Lafay-Cousin L; Holm S; Qaddoumi I; Nicolin G; Bartels U; Tabori U; Huang A; Bouffet E
Cancer; 2005 Jun; 103(12):2636-42. PubMed ID: 15861409
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reaction to carboplatin. Results of skin tests.
Menczer J; Barda G; Glezerman M; Hyat H; Brenner Y; Brickman CM; Tanai A
Eur J Gynaecol Oncol; 1999; 20(3):214-6. PubMed ID: 10410890
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to carboplatin in children.
Schiavetti A; Varrasso G; Maurizi P; Castello MA
Med Pediatr Oncol; 1999 Mar; 32(3):183-5. PubMed ID: 10064185
[TBL] [Abstract][Full Text] [Related]
15. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?
Kutlu A; Karabacak E; Aydin E; Ozturk S; Bozkurt B
Hum Exp Toxicol; 2014 Aug; 33(8):882-5. PubMed ID: 24203455
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab may facilitate drug desensitization in patients failing standard protocols.
Gemici Karaaslan HB; Karabag Yilmaz E; Gulmez R; Canpolat N; Kiykim A; Cokugras HC
Pediatr Allergy Immunol; 2022 May; 33(5):e13783. PubMed ID: 35616895
[No Abstract] [Full Text] [Related]
17. Hypersensitivity reactions to intraperitoneal administration of carboplatin in ovarian cancer: the first report of a case.
Shukunami K; Kurokawa T; Kawakami Y; Kubo M; Kotsuji F
Gynecol Oncol; 1999 Mar; 72(3):431-2. PubMed ID: 10053120
[TBL] [Abstract][Full Text] [Related]
18. In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma".
Lafay-Cousin L; Bouffet E
Support Care Cancer; 2012 Apr; 20(4):875-6. PubMed ID: 22076619
[No Abstract] [Full Text] [Related]
19. Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation.
Jones R; Ryan M; Friedlander M
Gynecol Oncol; 2003 Apr; 89(1):112-5. PubMed ID: 12694663
[TBL] [Abstract][Full Text] [Related]
20. Re: In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma".
Genc DB; Canpolat C; Berrak SG
Support Care Cancer; 2012 Jun; 20(6):1119-20. PubMed ID: 22391593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
